Editorial: More Conflicts Come to Light at Stem Cell Institute
By Editorial,
The Sacramento Bee
| 05. 25. 2013
With a new chairman, Jonathan Thomas, the California Institute for Regenerative Medicine claims it has turned a page. Thomas has vowed to be aggressive in avoiding conflicts in dispersing millions of public dollars for stem cell research.
Yet serious conflicts continue to be revealed involving CIRM. The latest one throws into question a $20 million grant awarded last year to StemCells Inc., a company that wants to transplant neural stem cells to treat Alzheimer's disease.
The institute's oversight board approved the award in September, following a lobbying effort by Robert Klein, a former chairman of the oversight board who authored Proposition 71, the initiative that created the stem cell institute. As part of that effort, Klein last year donated $21,000 to CIRM so it could send six of its in-house science officers to a conference in Japan, where Klein had special access to them.
Prior to this lobbying campaign, the institute's outside scientific reviewers recommended twice against awarding the money to StemCells Inc. Yet following Klein's efforts, the oversight board overruled them, agreeing on a 7-5 vote to approve the...
Related Articles
By Anna Collinson and Jo Adnitt, BBC | 08.18.2026
At least 30 children, most of them British, are feared to have been conceived by IVF treatment in northern Cyprus using the wrong sperm or egg donors.
In each case, the parents suspect they did not get the donors they...
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Dan Falk, Nautilus | 08.20.2026
The pseudoscience of eugenics, founded on the mistaken notion that nature envisions some “right” combination of genes, and that selective breeding can improve the human race, is making a comeback. While the heyday of eugenics was a century ago, the...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...